The DOI matches its Crossref record; the references it cites are not checked yet.
Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making?
Abstract
Point-of-care testing (POCT) is the analysis of patient specimens outside the clinical laboratory, near or at the site of patient care, usually performed by clinical staff without laboratory training, although it also encompasses patient self-monitoring. It is able to provide a rapid result near the patient and which can be acted upon immediately. The key driver is the concept that clinical decision making may be delayed when samples are sent to the clinical laboratory. Balanced against this are considerations of increased costs for purchase and maintenance of equipment, staff training, connectivity to the laboratory information system (LIS), quality control (QC) and external quality assurance (EQA) procedures, all required for accreditation under ISO 22870. The justification for POCT depends upon being able to demonstrate that a more timely result (shorter turnaround times (TATs)) is able to leverage a clinically important advantage in decision making compared with the central laboratory (CL). In the four decades since POCT was adapted for the self-monitoring of blood glucose levels by subjects with diabetes, numerous new POCT methodologies have become available, enabling the clinician to receive results and initiate treatment more rapidly. However, these instruments are often operated by staff not trained in laboratory medicine and hence are prone to errors in the analytical phase (as opposed to laboratory testing where the analytical phase has the least errors). In some environments, particularly remote rural settings, the CL may be at a considerable distance and timely availability of cardiac troponins and other analytes can triage referrals to the main centers, thus avoiding expensive unnecessary patient transportation costs. However, in the Emergency Department, availability of more rapid results with POCT does not always translate into shorter stays due to other barriers to implementation of care. In this review, we apply the principles of evidence-based laboratory medicine (EBLM) looking for high quality systematic reviews and meta-analyses, ideally underpinned by randomized controlled trials (RCTs), looking for evidence of whether POCT confers any advantage in clinical decision making in different scenarios.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, TAT has evolved from an internal productivity measure to a key performance indicator (KPI) directly linked to patient safety and institutional efficiency [4].”
From Impact of Laboratory Turnaround Time on Clinical Decision-Making and Patient Outcomes (2024) · cites this paper as [4]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 170 · Cited by 189
Research works printed but not linked: 25
- Hawkins RC., 2007, Clin Biochem Rev, 28, 179
- Tsai WW, 1994, Clin Therapeut, 16, 898
- O'Kane M., 2014, Point of Care, 31, 1, 10.1097/POC.10.1097/POC.0000000000000008 · doi:10.1097/poc
- Heneghan CJ, 2016, Cochrane Database Syst Rev, 7, CD003839
- Sharma P, 2015, Health Technol Assess, 19, 1
- Aabenhus R, 2014, Cochrane Database Syst Rev, CD010130
- Shephard MD, 2005, Rural Remote Health, 5, 371
- Shephard MD., 2006, Clin Biochem Rev, 27, 161
- St John A, 2015, Aust Fam Physician, 44, 10
- Hobbs FD, 1997, Health Technol Assess (Winchester, England), 1, 1
- Health Quality Ontario, 2009, Ont Health Technol Assess Ser, 9, 1
- Jacobsz M, 2007, S Afr Med J, 97, 805
- Malanda UL, 2012, Cochrane Database Syst Rev, 1, CD005060
- External Experts, 2011, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation
- Florkowski C, 2010, N Z Med J, 123, 43
- Grieve R, 1999, Health Technol Assess (Winchester, England), 3, 1
- Khunti K, 2006, Br J Gen Pract, 56, 511
- St John A., 2010, Clin Biochem Rev, 31, 111
- Weiss AJ, 2006, Overview of Emergency Department Visits in the United States, 2011: Statistical Brief #174. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs
- Barrett ML, 2006, Utilization of Intensive Care Services, 2011: Statistical Brief #185. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs
- Purcarea A, 2016, J Med Life, 9, 74
- Joosen AM, 2014, Clin Chem Lab Med, 52, e231
- Wier LM, 2006, Overview of Children in the Emergency Department, 2010: Statistical Brief #157. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs
- Doan Q, 2014, Cochrane Database Syst Rev, 9, CD006452
- Niska R, 2010, Natl Health Stat Rep, 26, 1
Metadata
- Authors
- Florkowski, C., Don-Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., & Zemlin, A.
- Affiliations
- Canterbury Health Laboratories (NZ)
- LifeLabs, Toronto, Canada;
- Hospital Mutua Terrassa, Barcelona, Spain;
- DynaLIFE Medical Labs, Edmonton, Canada;
- Centre Hospitalier Universitaire de Rouen (FR)
- National Health Laboratory Service (ZA)
- Corresponding author
- Florkowski, Christopher
- Venue
- Critical Reviews in Clinical Laboratory Sciences
- Publisher
- Informa UK Limited
- Published
- 2017-11-17
- Volume
- 54
- Issue
- 7-8
- Pages
- 471-494
- ISSN
- 1040-8363 (ISSN-L)
- 1549-781X
- OpenAlex
- W2768394516
- Cited by
- 189
- References
- 170
- Citations by year
- 2026: 10 · 2025: 34 · 2024: 31 · 2023: 28 · 2022: 22 · 2021: 21 · 2020: 25 · 2019: 13 · 2018: 3
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Clinical Laboratory Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
- Keywords
- point-of-care testing, evidence-based laboratory medicine, clinical decision-making, turnaround time, central laboratory comparison, patient self-monitoring, blood glucose monitoring, diabetes mellitus, cardiac troponin, emergency department, rural health care, laboratory information system integration, quality control, external quality assurance, analytical error
- MeSH terms
- Clinical Decision-Making, Point-of-Care Testing, Humans, Time Factors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making? https://app.cochat.ai/papers/10.1080/10408363.2017.1399336
- The paper
- Florkowski, C., Don-Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., & Zemlin, A. (2017). Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making? Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.1080/10408363.2017.1399336
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.